Fundraising Fox

Skeletalis

4 known investors

Find your way into Skeletalis

Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling. The company translates bone biology research into therapies designed to protect and rebuild bone.

BiotechDeep TechHealthtech

Investors · 4

age1San Francisco · $500K – $4M
Pillar VCBoston · $50K – $4M
KdT VenturesreportedAustin · $500K – $3M

Also in the syndicate · 1

Slocum Management

Funding

SEC filings, press & company announcements

$8M disclosed across 1 of 2 rounds · 2025

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Startup emerges with $8m to combat musculoskeletal diseaseslongevity.technology · Nov 2025Skeletalis secures $8m to advance targeted osteoporosis therapy – Women's Tabloidwomenstabloid.com · Nov 2025Healthcare spending graphed, the longevity space and more.liverpoollane.beehiiv.com · Nov 2025Skeletalis emerges from stealth with $8m seed round to develop precision medicine for osteoporosisfuturefemhealth.com · Nov 2025Skeletalis Raises $8M in Fundingfinsmes.com · Nov 2025Skeletalis Raises $8M for Osteoporosis Treatmentskeletalis.bio · Nov 2025

Frequently asked questions

What does Skeletalis do?
Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling. The company translates bone biology research into therapies designed to protect and rebuild bone.
Who are Skeletalis's investors?
Skeletalis's investors include age1, Pillar VC, KdT Ventures.
How much funding has Skeletalis raised?
Skeletalis has disclosed $8M raised across 1 of its 2 known rounds.